Rare diseases
Investigational molecules
Locations
Back to France1 504 clinical trials in Toulouse, France across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Effects and Safety of Ianalumab in Adults with Lupus Nephritis Who Completed Previous Treatment
FranceStudy of Sacituzumab Tirumotecan and Bevacizumab for Patients with Recurrent Ovarian Cancer
FranceStudy on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
FranceStudy on the Effectiveness of Etoposide, Carboplatin, and Cisplatin in Patients with Localized Digestive Neuroendocrine Carcinomas
FranceStudy on Stopping Dupilumab in Patients with Severe Asthma Who Have Been on the Drug for Over 3 Years
FranceStudy on the Effects of Pitolisant Hydrochloride for Patients with Prader-Willi Syndrome
FranceStudy on Colchicine and Aspirin for Improving Heart Health in Adults with Type 2 Diabetes Without Previous Heart Events
FranceStudy on Pembrolizumab for Patients with Early Triple-Negative Breast Cancer Responding Well to Initial Treatment
FranceStudy on the Effectiveness of Cemiplimab, Carboplatin, and Paclitaxel for Unfit or Elderly Patients with Unresectable Stage III Non-Small Cell Lung Cancer
FranceStudy of Epcoritamab, Lenalidomide, and Rituximab for Patients with Relapsed and Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
FranceStudy of Pozelimab and Cemdisiran for Adults with Geographic Atrophy from Age-Related Macular Degeneration
FranceStudy of Olverembatinib and Bosutinib for Patients with Chronic Phase Chronic Myeloid Leukemia
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on heart disease treatment, including trials for TTR amyloidosis and prevention of heart failure. Advanced therapeutic approaches using novel compounds like baxdrostat in combination with established medications.
Comprehensive cancer research targeting multiple types of malignancies, including head and neck cancer, gastric cancer, and advanced pancreatic cancer. Novel approaches using targeted therapies and immunotherapy combinations.
Advanced research in neurodegenerative conditions and movement disorders, including studies on frontotemporal dementia, essential tremor, and traumatic brain injury outcomes.
Studies investigating new treatments for inflammatory diseases, including innovative approaches for Crohn's disease, psoriatic arthritis, and myasthenia gravis.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
